Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,inventory,accountsPayable,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,totalCashflowsFromInvestingActivities,capitalExpenditures,changeToNetincome,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,epsTrailingTwelveMonths,currency,priceHint,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,exchange,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,country,website,maxAge,address1,industry
t0,GWHP,61279.0,63095800,65000,,-185654,,-185654,34847,4487,-95360,-95360,,-90294,,,,0,22075,117435,17588,-90294,,-185654,-185654,4752739.0,185233.0,61279.0,2062.0,246512.0,59966.0,-5181426.0,430000.0,6825.0,185233.0,430000.0,3020.0,243492.0,651.0,209598.0,24388.0,16032.0,-86488.0,3512.0,2768.0,90000.0,-125789.0,-129301.0,291.0,-21413.0,-651.0,,,,58259.0,en-US,US,EQUITY,False,Delayed Quote,-5.882356,0.32 - 0.355,0.34,0.0,0.0,0,0,finmb_254790995,Other OTC,Global WholeHealth Partners Corporation,USD,360203,167242,0.025000006,0.08474579,0.295 - 2.17,-1.8500001,-0.8525346,0.295,2.17,1558310400,-0.002,USD,4,0.0,0.42325714,-0.10325715,-0.24395843,0.5440217,-0.22402173,-0.41178823,20190656,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.32,1630526315,-0.02000001,0.33855,0.355,0.32,88813,GLOBAL WHOLEHEALTH PARTNERS COR,us_market,PREPRE,0.71,,,2.17,0.295,0.4233,0.544,360.2k,167.24k,63.1M,,37.7M,49.74%,0.00%,,,,,,,,,,,0.00%,"May 19, 2019",,1:500,"May 19, 2019","Jun 29, 2020","Dec 30, 2020",0.00%,"-1,609.65%","-2,079.91%","-29,797.74%",279.08k,0.00,,91.04k,,-4.65M,-0.0020,,6.83k,0,158.78k,259.11,1.32,0.00,-1.07M,668.76k,Value,92673,Healthcare,"Global WholeHealth Partners Corporation manufactures and markets various in vitro diagnostic test kits in the United States. It offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as point-of-care, which includes hospitals, physicians' offices, and medical clinics. The company was incorporated in 2013 and is based in San Clemente, California.",San Clemente,702 318 7554,CA,United States,http://gwhpcorp.com,86400,227 Avenida Oliva,Diagnostics & Research
t-1,GWHP,156933.0,63095800,139010,,-247163,,-247163,67038,4841,-201207,-201207,,-45956,,,,0,15385,216592,10544,-45956,,-247163,-247163,4752739.0,196146.0,156933.0,1845.0,353079.0,59966.0,-4995772.0,340000.0,132614.0,196146.0,340000.0,3311.0,349768.0,,214603.0,8356.0,-37965.0,76410.0,416410.0,11552.0,340000.0,118117.0,-294788.0,194.0,-62456.0,-651.0,-3505.0,-3505.0,,153622.0,en-US,US,EQUITY,False,Delayed Quote,-5.882356,0.32 - 0.355,0.34,0.0,0.0,0,0,finmb_254790995,Other OTC,Global WholeHealth Partners Corporation,USD,360203,167242,0.025000006,0.08474579,0.295 - 2.17,-1.8500001,-0.8525346,0.295,2.17,1558310400,-0.002,USD,4,0.0,0.42325714,-0.10325715,-0.24395843,0.5440217,-0.22402173,-0.41178823,20190656,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.32,1630526315,-0.02000001,0.33855,0.355,0.32,88813,GLOBAL WHOLEHEALTH PARTNERS COR,us_market,PREPRE,0.71,,,2.17,0.295,0.4233,0.544,360.2k,167.24k,63.1M,,37.7M,49.74%,0.00%,,,,,,,,,,,0.00%,"May 19, 2019",,1:500,"May 19, 2019","Jun 29, 2020","Dec 30, 2020",0.00%,"-1,609.65%","-2,079.91%","-29,797.74%",279.08k,0.00,,91.04k,,-4.65M,-0.0020,,6.83k,0,158.78k,259.11,1.32,0.00,-1.07M,668.76k,Value,92673,Healthcare,"Global WholeHealth Partners Corporation manufactures and markets various in vitro diagnostic test kits in the United States. It offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as point-of-care, which includes hospitals, physicians' offices, and medical clinics. The company was incorporated in 2013 and is based in San Clemente, California.",San Clemente,702 318 7554,CA,United States,http://gwhpcorp.com,86400,227 Avenida Oliva,Diagnostics & Research
t-2,GWHP,-59735.0,63095800,69253,,-4204002,,-4204002,3762103,91036,-3740320,-3740320,,-19932,,,,0,241624,3981944,150588,-463682,,-4204002,-4204002,4628908.0,241443.0,-59735.0,4306.0,181708.0,59966.0,-4748609.0,,14497.0,241443.0,,,181708.0,,152147.0,46321.0,45049.0,596840.0,596840.0,-12358.0,340000.0,13829.0,-583011.0,194.0,-128775.0,-651.0,-3505.0,-3505.0,3700000.0,-59735.0,en-US,US,EQUITY,False,Delayed Quote,-5.882356,0.32 - 0.355,0.34,0.0,0.0,0,0,finmb_254790995,Other OTC,Global WholeHealth Partners Corporation,USD,360203,167242,0.025000006,0.08474579,0.295 - 2.17,-1.8500001,-0.8525346,0.295,2.17,1558310400,-0.002,USD,4,0.0,0.42325714,-0.10325715,-0.24395843,0.5440217,-0.22402173,-0.41178823,20190656,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.32,1630526315,-0.02000001,0.33855,0.355,0.32,88813,GLOBAL WHOLEHEALTH PARTNERS COR,us_market,PREPRE,0.71,,,2.17,0.295,0.4233,0.544,360.2k,167.24k,63.1M,,37.7M,49.74%,0.00%,,,,,,,,,,,0.00%,"May 19, 2019",,1:500,"May 19, 2019","Jun 29, 2020","Dec 30, 2020",0.00%,"-1,609.65%","-2,079.91%","-29,797.74%",279.08k,0.00,,91.04k,,-4.65M,-0.0020,,6.83k,0,158.78k,259.11,1.32,0.00,-1.07M,668.76k,Value,92673,Healthcare,"Global WholeHealth Partners Corporation manufactures and markets various in vitro diagnostic test kits in the United States. It offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as point-of-care, which includes hospitals, physicians' offices, and medical clinics. The company was incorporated in 2013 and is based in San Clemente, California.",San Clemente,702 318 7554,CA,United States,http://gwhpcorp.com,86400,227 Avenida Oliva,Diagnostics & Research
t-3,GWHP,-41707.0,63095800,443750,,-11629,,-11629,11629,0,-455379,-455379,,-19932,,,,0,0,455379,0,443750,,-11629,-11629,444784.0,65747.0,-41707.0,1500.0,24040.0,58116.0,-544607.0,,668.0,65747.0,,,24040.0,,23372.0,1372.0,0.0,62875.0,62875.0,-50675.0,340000.0,571.0,-62304.0,194.0,-128775.0,-651.0,-3505.0,-3505.0,3700000.0,-41707.0,en-US,US,EQUITY,False,Delayed Quote,-5.882356,0.32 - 0.355,0.34,0.0,0.0,0,0,finmb_254790995,Other OTC,Global WholeHealth Partners Corporation,USD,360203,167242,0.025000006,0.08474579,0.295 - 2.17,-1.8500001,-0.8525346,0.295,2.17,1558310400,-0.002,USD,4,0.0,0.42325714,-0.10325715,-0.24395843,0.5440217,-0.22402173,-0.41178823,20190656,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.32,1630526315,-0.02000001,0.33855,0.355,0.32,88813,GLOBAL WHOLEHEALTH PARTNERS COR,us_market,PREPRE,0.71,,,2.17,0.295,0.4233,0.544,360.2k,167.24k,63.1M,,37.7M,49.74%,0.00%,,,,,,,,,,,0.00%,"May 19, 2019",,1:500,"May 19, 2019","Jun 29, 2020","Dec 30, 2020",0.00%,"-1,609.65%","-2,079.91%","-29,797.74%",279.08k,0.00,,91.04k,,-4.65M,-0.0020,,6.83k,0,158.78k,259.11,1.32,0.00,-1.07M,668.76k,Value,92673,Healthcare,"Global WholeHealth Partners Corporation manufactures and markets various in vitro diagnostic test kits in the United States. It offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as point-of-care, which includes hospitals, physicians' offices, and medical clinics. The company was incorporated in 2013 and is based in San Clemente, California.",San Clemente,702 318 7554,CA,United States,http://gwhpcorp.com,86400,227 Avenida Oliva,Diagnostics & Research
